{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:49:10Z","timestamp":1791586150337,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["10.55776\/P35312"],"award-info":[{"award-number":["10.55776\/P35312"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"DOI":"10.1007\/s00216-026-06851-1","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:59:41Z","timestamp":1791583181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel substrate for CYP3A4 phenotyping:\u00a0in vitro biotransformation of hubamine into butanone"],"prefix":"10.1007","author":[{"given":"Rebecca","family":"Hofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus R.","family":"Liedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Troppmair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Dank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Gstach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kammerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Ruzsanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"issue":"5","key":"6851_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2174\/138920011795495321","volume":"12","author":"N Pinto","year":"2011","unstructured":"Pinto N, Dolan ME. Clinically relevant genetic variations in drug metabolizing enzymes. Curr Drug Metab. 2011;12(5):487\u201397. https:\/\/doi.org\/10.2174\/138920011795495321.","journal-title":"Curr Drug Metab"},{"key":"6851_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1201083","author":"JS Kim","year":"2023","unstructured":"Kim JS, Shim S, Yee J, Choi KH, Gwak HS. Effects of CYP3A4*22 polymorphism on trough concentration of tacrolimus in kidney transplantation: a systematic review and meta-analysis. Front Pharmacol. 2023. https:\/\/doi.org\/10.3389\/fphar.2023.1201083.","journal-title":"Front Pharmacol"},{"key":"6851_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00012","author":"K Klein","year":"2013","unstructured":"Klein K, Zanger UM. Pharmacogenomics of Cytochrome P450 3A4: recent progress toward the \u201cmissing heritability\u201d problem. Front Genet. 2013. https:\/\/doi.org\/10.3389\/fgene.2013.00012.","journal-title":"Front Genet"},{"issue":"3","key":"6851_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/futurepharmacol2030018","volume":"2","author":"M Ortega-Ruiz","year":"2022","unstructured":"Ortega-Ruiz M, Soria-Chacartegui P, Villapalos-Garc\u00eda G, Abad-Santos F, Zubiaur P. The pharmacogenetics of treatment with quetiapine. Future Pharmacol. 2022;2(3):276\u201386. https:\/\/doi.org\/10.3390\/futurepharmacol2030018.","journal-title":"Future Pharmacol"},{"key":"6851_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.912618","author":"Q Zhai","year":"2022","unstructured":"Zhai Q, Lee M, Gelder T, Swen JJ. Why we need to take a closer look at genetic contributions to CYP3A activity. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2022.912618.","journal-title":"Front Pharmacol"},{"key":"6851_CR6","doi-asserted-by":"publisher","unstructured":"Kesel PMMD, E. LW, Stove CP. Alternative Sampling Strategies for Cytochrome P450 Phenotyping. Clin Pharmacokinet. 2016;55(2):169\u2013184. https:\/\/doi.org\/10.1007\/s40262-015-0306-y.","DOI":"10.1007\/s40262-015-0306-y"},{"key":"6851_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.730637","author":"KI Lorenzini","year":"2021","unstructured":"Lorenzini KI, Desmeules J, Rollason V, Bertin S, Besson M, Daali Y, et al. CYP450 genotype\u2014phenotype concordance using the Geneva micrococktail in a clinical setting. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.730637.","journal-title":"Front Pharmacol"},{"issue":"6","key":"6851_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11060831","volume":"11","author":"A Catino","year":"2019","unstructured":"Catino A, Gennaro GD, Gilio AD, Facchini L, Galetta D, Palmisani J, et al. Breath analysis: a systematic review of volatile organic compounds (VOCs) in diagnostic and therapeutic management of pleural mesothelioma. Cancers (Basel). 2019;11(6):831. https:\/\/doi.org\/10.3390\/cancers11060831.","journal-title":"Cancers (Basel)"},{"key":"6851_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202500492","author":"V Stock","year":"2025","unstructured":"Stock V, Hofer R, Liedl KR, Troppmair J, Langer T, Gstach H, et al. Towards the use of metabolic volatiles in breath for determining drug response: gstachamine as an unlabeled substrate to measure CYP3A4 activity. ChemMedChem. 2025. https:\/\/doi.org\/10.1002\/cmdc.202500492.","journal-title":"ChemMedChem"},{"issue":"18","key":"6851_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26185514","volume":"26","author":"YL Pham","year":"2021","unstructured":"Pham YL, Beauchamp J. Breath biomarkers in diagnostic applications. Molecules. 2021;26(18):5514. https:\/\/doi.org\/10.3390\/molecules26185514.","journal-title":"Molecules"},{"issue":"4","key":"6851_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/fpc.0000000000000121","volume":"25","author":"SL Safgren","year":"2015","unstructured":"Safgren SL, Suman VJ, Kosel ML, Gilbert JA, Buhrow SA, Black JL, et al. Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen. Pharmacogenet Genomics. 2015;25(4):157\u201363. https:\/\/doi.org\/10.1097\/fpc.0000000000000121.","journal-title":"Pharmacogenet Genomics"},{"key":"6851_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/B978-0-12-819967-1.00017-7","volume-title":"Breathborne biomarkers and the human volatilome","author":"AS Modak","year":"2020","unstructured":"Modak AS. 13C breath tests. In: Pleil JBCDJ, editor. Breathborne biomarkers and the human volatilome. San Diego: Elsevier; 2020. p. 273\u201387."},{"key":"6851_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-86450-9","author":"V Stock","year":"2025","unstructured":"Stock V, Hofer R, Lochmann F, Spanke V, Liedl KR, Troppmair J, et al. Tolterodine is a novel candidate for assessing CYP3A4 activity through metabolic volatiles to predict drug responses. Sci Rep. 2025. https:\/\/doi.org\/10.1038\/s41598-025-86450-9.","journal-title":"Sci Rep"},{"key":"6851_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108772","volume":"163","author":"V Stock","year":"2025","unstructured":"Stock V, Hofer R, Spanke V, Liedl KR, Troppmair J, Langer T, et al. Diisopromine as a non-labelled CYP3A4 substrate: implications for breath test development. Bioorg Chem. 2025;163:108772. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108772.","journal-title":"Bioorg Chem"},{"issue":"7","key":"6851_CR15","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1039\/c3an36756h","volume":"138","author":"P Mochalski","year":"2013","unstructured":"Mochalski P, King J, Klieber M, Unterkofler K, Hinterhuber H, Baumann M, et al. Blood and breath levels of selected volatile organic compounds in healthy volunteers. Analyst. 2013;138(7):2134\u201345. https:\/\/doi.org\/10.1039\/c3an36756h.","journal-title":"Analyst"},{"key":"6851_CR16","doi-asserted-by":"publisher","DOI":"10.1201\/b16109","volume-title":"Ion mobility spectrometry","author":"GA Eiceman","year":"2013","unstructured":"Eiceman GA, Karpas Z, Hill HH. Ion mobility spectrometry. CRC press; 2013."},{"key":"6851_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijms.2023.117012","author":"PC Moura","year":"2023","unstructured":"Moura PC, Vassilenko V. Contemporary ion mobility spectrometry applications and future trends towards environmental, health and food research: a review. Int J Mass Spectrom. 2023. https:\/\/doi.org\/10.1016\/j.ijms.2023.117012.","journal-title":"Int J Mass Spectrom"},{"issue":"9","key":"6851_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26093992","volume":"26","author":"C Schulz","year":"2025","unstructured":"Schulz C, Stegen S, Jung F, K\u00fcpper J-H. Mono-CYP CHO model: a recombinant Chinese hamster ovary cell platform for investigating CYP-specific tamoxifen metabolism. Int J Mol Sci. 2025;26(9):3992. https:\/\/doi.org\/10.3390\/ijms26093992.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6851_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/jcb-15002","volume":"1","author":"N Herzog","year":"2015","unstructured":"Herzog N, Katzenberger N, Martin F, Schmidtke KU, K\u00fcpper JH. Generation of cytochrome P450 3A4-overexpressing HepG2 cell clones for standardization of hepatocellular testosterone 6\u03b2-hydroxylation activity. Journal of Cellular Biotechnology. 2015;1(1):15\u201326. https:\/\/doi.org\/10.3233\/jcb-15002.","journal-title":"Journal of Cellular Biotechnology"},{"key":"6851_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tox.2018.11.008","volume":"412","author":"S Steinbrecht","year":"2019","unstructured":"Steinbrecht S, K\u00f6nig R, Schmidtke K-U, Herzog N, Scheibner K, Kr\u00fcger-Genge A, et al. Metabolic activity testing can underestimate acute drug cytotoxicity as revealed by HepG2 cell clones overexpressing cytochrome P450 2C19 and 3A4. Toxicology. 2019;412:37\u201347. https:\/\/doi.org\/10.1016\/j.tox.2018.11.008.","journal-title":"Toxicology"},{"key":"6851_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-026-07935-y","author":"S Kammerer","year":"2026","unstructured":"Kammerer S, Herzog N, Jenchen T, Stock V, Hofer R, Ruzsanyi V, et al. Phenotypical and functional characterization of a HepG2 cell clone stably overexpressing cytochrome P450 (CYP) 2C9. BMC Res Notes. 2026. https:\/\/doi.org\/10.1186\/s13104-026-07935-y.","journal-title":"BMC Res Notes"},{"issue":"3","key":"6851_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1063\/1.556018","volume":"27","author":"EPL Hunter","year":"1998","unstructured":"Hunter EPL, Lias SG. Evaluated gas phase basicities and proton affinities of molecules: an update. J Phys Chem Ref Data. 1998;27(3):413\u2013656. https:\/\/doi.org\/10.1063\/1.556018.","journal-title":"J Phys Chem Ref Data"},{"issue":"6","key":"6851_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1255\/ejms.684","volume":"10","author":"DJ Goebbert","year":"2004","unstructured":"Goebbert DJ, Wenthold PG. Water dimer proton affinity from the kinetic method: dissociation energy of the water dimer. Eur J Mass Spectrom. 2004;10(6):837\u201345. https:\/\/doi.org\/10.1255\/ejms.684.","journal-title":"Eur J Mass Spectrom"},{"issue":"21","key":"6851_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27217554","volume":"27","author":"H Schanzmann","year":"2022","unstructured":"Schanzmann H, Augustini ALRM, Sanders D, Dahlheimer M, Wigger M, Zech P-M, et al. Differentiation of monofloral honey using volatile organic compounds by HS-GCxIMS. Molecules. 2022;27(21):7554. https:\/\/doi.org\/10.3390\/molecules27217554.","journal-title":"Molecules"},{"key":"6851_CR25","unstructured":"Deutsches Institut f\u00fcr Normung e.V. DIN 32645: Chemische Analytik \u2013 Nachweis-, Erfassungs- und Bestimmungsgrenze unter Wiederholbedingungen \u2013 Begriffe, Verfahren, Auswertung. Berlin, Germany: Beuth Verlag GmbH; 2008. Report No.: DIN 32645:2008-11."},{"issue":"10","key":"6851_CR26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/j.1432-2277.2010.01089.x","volume":"23","author":"M Stockmann","year":"2010","unstructured":"Stockmann M, Lock JF, Malinowski M, Seehofer D, Puhl G, Pratschke J, et al. How to define initial poor graft function after liver transplantation? - a new functional definition by the LiMAx test. Transpl Int. 2010;23(10):1023\u201332. https:\/\/doi.org\/10.1111\/j.1432-2277.2010.01089.x.","journal-title":"Transpl Int"},{"issue":"4","key":"6851_CR27","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/7\/4\/046008","volume":"7","author":"V Ruzsanyi","year":"2013","unstructured":"Ruzsanyi V. Ion mobility spectrometry for pharmacokinetic studies-\u2013exemplary application. J Breath Res. 2013;7(4):046008. https:\/\/doi.org\/10.1088\/1752-7155\/7\/4\/046008.","journal-title":"J Breath Res"},{"issue":"18","key":"6851_CR28","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1007\/s00216-025-05933-w","volume":"417","author":"H Schanzmann","year":"2025","unstructured":"Schanzmann H, Gaar S, Keip S, Telgheder U, Sielemann S. Comparison of the quantification performance of thermal desorption GC-IMS and GC-MS in VOC analysis. Anal Bioanal Chem. 2025;417(18):4179\u201398. https:\/\/doi.org\/10.1007\/s00216-025-05933-w.","journal-title":"Anal Bioanal Chem"},{"key":"6851_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/9781118682883","author":"AM Ellis","year":"2014","unstructured":"Ellis AM, Mayhew CA. Proton Transfer Reaction Mass Spectrometry. 2014. https:\/\/doi.org\/10.1002\/9781118682883.","journal-title":"Proton Transfer Reaction Mass Spectrometry"},{"issue":"5","key":"6851_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1039\/A827347Z","volume":"27","author":"W Lindinger","year":"1998","unstructured":"Lindinger W, Jordan A. Proton-transfer-reaction mass spectrometry (PTR\u2013MS): on-line monitoring of volatile organic compounds at pptv levels. Chem Soc Rev. 1998;27(5):347. https:\/\/doi.org\/10.1039\/A827347Z.","journal-title":"Chem Soc Rev"},{"issue":"3","key":"6851_CR31","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1021\/cr800364q","volume":"109","author":"RS Blake","year":"2009","unstructured":"Blake RS, Monks PS, Ellis AM. Proton-transfer reaction mass spectrometry. Chem Rev. 2009;109(3):861\u201396. https:\/\/doi.org\/10.1021\/cr800364q.","journal-title":"Chem Rev"},{"issue":"3","key":"6851_CR32","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/3\/3\/036004","volume":"3","author":"W Vautz","year":"2009","unstructured":"Vautz W, Nolte J, Fobbe R, Baumbach JI. Breath analysis\u2014performance and potential of ion mobility spectrometry. J Breath Res. 2009;3(3):036004. https:\/\/doi.org\/10.1088\/1752-7155\/3\/3\/036004.","journal-title":"J Breath Res"},{"issue":"11","key":"6851_CR33","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.5194\/amt-7-3763-2014","volume":"7","author":"M M\u00fcller","year":"2014","unstructured":"M\u00fcller M, Mikoviny T, Feil S, Haidacher S, Hanel G, Hartungen E, et al. A compact PTR-ToF-MS instrument for airborne measurements of volatile organic compounds at high spatiotemporal resolution. Atmos Meas Tech. 2014;7(11):3763\u201372. https:\/\/doi.org\/10.5194\/amt-7-3763-2014.","journal-title":"Atmos Meas Tech"},{"issue":"5","key":"6851_CR34","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.trac.2010.12.007","volume":"30","author":"I M\u00e1rquez-Sillero","year":"2011","unstructured":"M\u00e1rquez-Sillero I, Aguilera-Herrador E, C\u00e1rdenas S, Valc\u00e1rcel M. Ion-mobility spectrometry for environmental analysis. TrAC Trends Anal Chem. 2011;30(5):677\u201390. https:\/\/doi.org\/10.1016\/j.trac.2010.12.007.","journal-title":"TrAC Trends Anal Chem"},{"key":"6851_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2023.117438","volume":"170","author":"H Parastar","year":"2024","unstructured":"Parastar H, Weller P. Towards greener volatilomics: is GC-IMS the new Swiss army knife of gas phase analysis? TrAC Trends Anal Chem. 2024;170:117438. https:\/\/doi.org\/10.1016\/j.trac.2023.117438.","journal-title":"TrAC Trends Anal Chem"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06851-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-026-06851-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06851-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:59:43Z","timestamp":1791583183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-026-06851-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":35,"alternative-id":["6851"],"URL":"https:\/\/doi.org\/10.1007\/s00216-026-06851-1","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}